Authors: David Nash, MD, MBA, et.al.
A “one drug fits all” approach does not work for elderly patients because they are exposed to unique health variables that are rare in younger patients. This report explains the pharmacological, physiological and epidemiological reasons why therapy for this population must be personalized to avoid the risks of sub-optimal pharmaceutical care for older Americans. A fact sheet and annotated PowerPoint slides related to this report are available.